Semperit AG Holding | WebDisclosure

Basculer en Français

10761	Companies
231244	Keywords
159650	Articles
122925	Press releases

Home
Companies
Semperit AG Holding

BRIEF

published on 07/15/2026 at 09:05, 7 days 8 hours ago

Semperit AG Holding : Recommandation relevée à « Achat » suite à de solides performances au deuxième trimestre

NuWays AG Semperit AG Holding Prévisions D'EBITDA Prix Cible Performances Du Deuxième Trimestre
BRIEF

published on 07/15/2026 at 09:05, 7 days 8 hours ago

Semperit AG Holding: Upgraded to 'BUY' Following Strong Q2 Performance

EBITDA Forecast NuWays AG Target Price Semperit AG Holding Q2 Performance
PRESS RELEASE

published on 07/15/2026 at 09:00, 7 days 8 hours ago

Original-Research: Semperit AG Holding (von NuWays AG): BUY
Semperit AG Holding raises FY26 guidance after strong Q2 performance, with operating EBITDA doubling to around €40m. The company shows resilience against raw material price increases

Semperit AG Holding Operating EBITDA Pricing Adjustments FY26 Guidance Raw Material Sensitivity
BRIEF

published on 07/14/2026 at 11:03, 8 days 6 hours ago

Semperit AG Holding annonce de solides résultats pour le deuxième trimestre 2026

Semperit AG Holding Croissance Des Bénéfices Prévisions D'EBITDA Incertitude Économique Performances Du Deuxième Trimestre 2026
BRIEF

published on 07/14/2026 at 11:03, 8 days 6 hours ago

Semperit AG Holding Reports Strong Q2 2026 Earnings

Economic Uncertainty EBITDA Forecast Earnings Growth Semperit AG Holding Q2 2026 Performance
PRESS RELEASE

published on 07/14/2026 at 10:58, 8 days 6 hours ago

EQS-Adhoc: Semperit AG Holding: Operating earnings in Q2 2026 significantly above the prior-year figure; full-year earnings forecast raised
Semperit AG Holding reports significantly higher operating earnings in Q2 2026 compared to the previous year. Full-year earnings forecast raised due to strong business performance

Business Performance Semperit AG Holding Operating Earnings Full-year Forecast Q2 2026
BRIEF

published on 06/17/2026 at 09:05, 1 month 5 days ago

B&C Increases Stake in Semperit AG Holding to 63.4%

Shareholder Value Investment Recommendation Semperit Voluntary Takeover B&C Stake
BRIEF

published on 06/17/2026 at 09:05, 1 month 5 days ago

B&C porte sa participation dans Semperit AG Holding à 63,4 %

Valeur Actionnariale Recommandation D'investissement Semperit Prise De Contrôle Volontaire B&C Stake
PRESS RELEASE

published on 06/17/2026 at 09:00, 1 month 5 days ago

Original-Research: Semperit AG Holding (von NuWays AG): BUY
NuWays AG releases research on Semperit AG Holding, updating recommendation to BUY with target price of EUR 21.5. B&C increases stake to 63.4%, satisfied with outcome. Investment case intact, no material implications expected

Investment NuWays AG Strategy Stake Increase Semperit AG Holding
BRIEF

published on 05/15/2026 at 09:05, 2 months 7 days ago

Semperit AG Holding Reports Strong Q1 as Earnings Surge

Revenue Growth Buy Recommendation Semperit AG Holding Cost Management Q1 Earnings

Accesswire

Published on 07/22/2026 at 15:00, 2 hours 55 minutes ago

Karbon-X Secures Technical Advisory Engagement for Nature-Based Carbon Project in Libya
Published on 07/22/2026 at 15:00, 2 hours 55 minutes ago

Additional Infant Patient to Receive Jaguar Health's Crofelemer for Compassionate Use for Treatment of Intestinal Failure (IF) Due to Microvillus Inclusion Disease (MVID)
Published on 07/22/2026 at 14:50, 3 hours 5 minutes ago

Hillcrest Enters AI Datacenter Ecosystem
Published on 07/22/2026 at 14:35, 3 hours 20 minutes ago

Wi2Wi Reports Significant Manufacturing Yield Improvement in Q2 2026
Published on 07/22/2026 at 14:30, 3 hours 25 minutes ago

As Ebola Death Toll Surpasses 930 Within Two Months, NanoViricides Has Applied to the DR Congo Regulatory Agency for Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola

View all ACCESSWIRE

EQS Group

Published on 07/22/2026 at 17:45, 10 minutes ago

VAZIVA SA: S1 2026 : VAZIVA RENFORCE LES FONDATIONS DE SA FUTURE CROISSANCE
Published on 07/22/2026 at 17:40, 14 minutes ago

VALBIOTIS SA: Les résultats de l’étude clinique REVERSE-IT publiés dans Nature Communications, une reconnaissance scientifique internationale majeure pour l’ingrédient Totum•63
Published on 07/22/2026 at 17:40, 14 minutes ago

VALBIOTIS SA: Results of the REVERSE-IT clinical study published in Nature Communications, a major international scientific recognition for the ingredient Totum•63
Published on 07/22/2026 at 16:49, 1 hour 5 minutes ago

Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
Published on 07/22/2026 at 16:30, 1 hour 24 minutes ago

Befar Group Achieves Mass Production of 6N-Grade High-Purity Hydrogen Fluoride

Les Echos

Published on 07/22/2026 at 17:45, 10 minutes ago

Groupe CRIT : 2026 first half revenue: €1.67 billion (+2.3% on an organic basis).
Published on 07/22/2026 at 17:45, 10 minutes ago

Groupe CRIT : Chiffre d’affaires du 1er semestre 2026 : 1,67 Md€ (+2,3% en organique).
Published on 07/22/2026 at 17:40, 15 minutes ago

Report on share repurchases from 15 to 21 July 2026
Published on 07/22/2026 at 17:40, 15 minutes ago

Déclaration des transactions sur actions propres réalisées du 15 au 21 juillet 2026
Published on 07/22/2026 at 15:26, 2 hours 28 minutes ago

Chiffres d'Affaires du 1er Trimestre de l'Exercice 2026/2027

View all LES ECHOS COMFI WIRE